[Treatment with danaparoid during pregnancy for a woman with a  cutenous allergy to low-molecular-weight heparin]  .
The authors describe a case of heparin-induced skin reaction due to two preparations of low molecular weight heparin in a pregnant woman. The main characteristics of heparin-related cutaneous allergy are reported. The use of an heparinoid, usually indicated for patients with heparin-induced thrombocytopenia, appeared to be efficient and safe for the mother and her fetus. An epidural analgesia was performed for labor analgesia, 24 hours after the last injection of danaparid of sodium.
de Saint-Blanquat
L
L
Service d'anesthésie-réanimation chirurgicale, hôpital Saint-Vincent-de-Paul, 74-82, avenue Denfert-Rochereau, 75014 Paris, France.
Simon
L
L
Toubas
M F
MF
Hamza
J
J
D000328:Adult; D015360:Analgesia, Epidural; D016362:Analgesia, Obstetrical; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D004338:Drug Combinations; D003875:Drug Eruptions / Q000150:complications*; D004342:Drug Hypersensitivity / Q000150:complications*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D013921:Thrombocytopenia / Q000139:chemically induced*
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; D006497:Heparan Sulfate; C035838:danaparoid
Traitement par le danaparoïde de sodium au cours de la grossesse chez une patiente présentant une allergie cutanée aux héparines de bas poids moléculaire.